Omabit

Omabit provides AI-powered software that lets pharma, biotech, and research teams analyze complex genomic, clinical, and other R&D data using natural-language questions

Biotech & Life Sciences

Sector

B2B SaaS

Model

01Company Overview

Omabit provides AI-powered software that lets pharma, biotech, and research teams analyze complex genomic, clinical, and other R&D data using natural-language questions. It runs analyses, checks results against published research, and produces reproducible outputs and write-ups, reducing analysis workflows from months to days.

02Backed By1 investor

BVBright Ventures→

03Recent Activity

Is this your company? Claim your profile

FROM Bright Ventures

Bright Ventures led a $2 million seed round for Omabit, an AI platform that helps life science companies analyze fragmented scientific evidence for drug development, clinical research and regulatory engagement. This marks Bright Ventures leading a seed round (its usual posture is participating).